PRLD · Prelude Therapeutics Inc · Investor Relations
$3.77
+0.10 (+2.72%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$309.24M
Shares
79.80M
Volume · Oct 5
254.09K
Avg daily vol (3M)
472.8K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-16 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-03-10 | Citizens Life Sciences Conference 2026 | Conference |
| 2025-11-12 | Prelude Therapeutics Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-06-11 | Goldman Sachs 46th Annual Global Healthcare Conference | Conference |
| 2025-06-05 | 2025 Jefferies Global Healthcare Conference | Conference |
| 2025-05-07 | Citizens Life Sciences Conference | Conference |
| 2025-03-11 | Barclays 27th Annual Global Healthcare Conference | Conference |
| 2024-12-02 | The Citizens JMP Hematology and Oncology Summit | Webcast |
| 2024-09-13 | PRT3789 Phase 1 Interim Clinical Data Update from 2024 ESMO Congress | Event |
Source: https://preludetx.com/investors/